Rochefort H - Search Results

1

Breast cancer cell invasiveness: correlation with protein kinase C activity and differential regulation by phorbol ester in estrogen receptor-positive and -negative cells.

Platet N, Prévostel C, Derocq D, Joubert D, Rochefort H, Garcia M. Platet N, et al. Among authors: rochefort h. Int J Cancer. 1998 Mar 2;75(5):750-6. doi: 10.1002/(sici)1097-0215(19980302)75:5<750::aid-ijc14>3.0.co;2-a. Int J Cancer. 1998. PMID: 9495244

2

Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells.

Garcia M, Derocq D, Freiss G, Rochefort H. Garcia M, et al. Among authors: rochefort h. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11538-42. doi: 10.1073/pnas.89.23.11538. Proc Natl Acad Sci U S A. 1992. PMID: 1454845 Free PMC article.

3

Cathepsin D: a protease involved in breast cancer metastasis.

Rochefort H, Capony F, Garcia M. Rochefort H, et al. Cancer Metastasis Rev. 1990 Dec;9(4):321-31. doi: 10.1007/BF00049522. Cancer Metastasis Rev. 1990. PMID: 1965795 Review.

4

Difference between R5020 and the antiprogestin RU486 in antiproliferative effects on human breast cancer cells.

Gill PG, Vignon F, Bardon S, Derocq D, Rochefort H. Gill PG, et al. Among authors: rochefort h. Breast Cancer Res Treat. 1987 Oct;10(1):37-45. doi: 10.1007/BF01806133. Breast Cancer Res Treat. 1987. PMID: 3689980

5

Why are estrogen-receptor-negative breast cancers more aggressive than the estrogen-receptor-positive breast cancers?

Sheikh MS, Garcia M, Pujol P, Fontana JA, Rochefort H. Sheikh MS, et al. Among authors: rochefort h. Invasion Metastasis. 1994-1995;14(1-6):329-36. Invasion Metastasis. 1994. PMID: 7657526 Review.

6

Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells.

Coopman P, Garcia M, Brünner N, Derocq D, Clarke R, Rochefort H. Coopman P, et al. Among authors: rochefort h. Int J Cancer. 1994 Jan 15;56(2):295-300. doi: 10.1002/ijc.2910560225. Int J Cancer. 1994. PMID: 8314314

7

Transfected cathepsin D stimulates high density cancer cell growth by inactivating secreted growth inhibitors.

Liaudet E, Derocq D, Rochefort H, Garcia M. Liaudet E, et al. Among authors: rochefort h. Cell Growth Differ. 1995 Sep;6(9):1045-52. Cell Growth Differ. 1995. PMID: 8519680

8

[Estrogens and breast cancer: from action mechanisms to clinical applications].

Garcia M, Rochefort H. Garcia M, et al. Among authors: rochefort h. Ann Endocrinol (Paris). 1995;56(5):543-5. Ann Endocrinol (Paris). 1995. PMID: 8597500 Review. French.

9

Biological and clinical significance of cathepsin D in breast cancer metastasis.

Garcia M, Platet N, Liaudet E, Laurent V, Derocq D, Brouillet JP, Rochefort H. Garcia M, et al. Among authors: rochefort h. Stem Cells. 1996 Nov;14(6):642-50. doi: 10.1002/stem.140642. Stem Cells. 1996. PMID: 8948022 Review.

10

Both estradiol and tamoxifen decrease proliferation and invasiveness of cancer cells transfected with a mutated estrogen receptor.

Garcia M, Derocq D, Platet N, Bonnet S, Brouillet JP, Touitou I, Rochefort H. Garcia M, et al. Among authors: rochefort h. J Steroid Biochem Mol Biol. 1997 Apr;61(1-2):11-7. doi: 10.1016/s0960-0760(96)00255-5. J Steroid Biochem Mol Biol. 1997. PMID: 9328205

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters